StrandAdvantage test for early-line and advanced-stage treatment decisions in solid tumors
نویسندگان
چکیده
منابع مشابه
StrandAdvantage test for early‐line and advanced‐stage treatment decisions in solid tumors
Comprehensive genetic profiling of tumors using next-generation sequencing (NGS) is gaining acceptance for guiding treatment decisions in cancer care. We designed a cancer profiling test combining both deep sequencing and immunohistochemistry (IHC) of relevant cancer targets to aid therapy choices in both standard-of-care (SOC) and advanced-stage treatments for solid tumors. The SOC report is p...
متن کاملLiquid Biopsy May Help Guide Treatment Decisions for Advanced Solid Tumors
“The fact that genomic mutations vary not only patient to patient but also change over time has been a constant challenge in cancer treatment, especially in the precision medicine era,” said Sumanta Kumar Pal, MD, ASCO expert in developmental therapeutics. “Having a good, reliable option beyond a tumor biopsy could have a major impact on our ability to select the right therapy for the right pat...
متن کاملTreatment for advanced tumors: SRC reclaims center stage.
The non–receptor protein tyrosine, Src, is a 60-kDa protein that is the archetypal member of a nine-gene family, including Src, Yes, Fyn, Lyn, Lck, Hck, Fgr, Blk, and Yrk, that plays a critical role in regulation of proliferation, differentiation, migration, adhesion, invasion, angiogenesis, and immune function (for detailed reviews, see refs. 1–4). All Src family kinases are myristoylated at t...
متن کاملEverolimus treatment in advanced solid tumors: a personal view
Everolimus is currently approved in four settings: progressive well differentiated pan-creatic neuroendocrine tumors (pNETs), metastatic renal cell carcinoma (mRCC), in patients who failed a treatment with tyro-sine kinase inhibitor; advanced hormone receptor positive HER-2 negative breast car-cinoma in combination with exemestane; and astrocytoma associated with tuberous sclerosis [1]. The app...
متن کاملTreatment of early stage thymic tumors: surgery and radiation therapy.
Tumors of the thymus are an uncommon entity, constituting 30% and 15% of anterior mediastinal masses in adults and children, respectively. The majority of these tumors are thymomas, with thymic carcinomas less common, and thymic carcinoids exceedingly rare. Recognition of the distinct clinicopathologic behavior of various thymic neoplasms is crucial to providing optimal treatment. Evidence guid...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cancer Medicine
سال: 2017
ISSN: 2045-7634
DOI: 10.1002/cam4.1037